<qa>  What is the goal of this clinical research study?The goal of this clinical research study is to learn if it is safe and practical to give fucosylated Tregs to patients who will receive a matched related donor MRD, a matched unrelated donor MUD, or cord blood transplant. Researchers also want to learn if these Tregs may prevent or reduce the effects of graft-versus host disease GVHD. GVHD can result from a reaction of the transplanted cord blood cells against certain tissues in the body. 